- Home
- MSI vs INM Comparison
MSI vs INM Comparison
Compare MSI & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSI
- INM
- Stock Information
- Founded
- MSI 1928
- INM 1981
- Country
- MSI United States
- INM Canada
- Employees
- MSI N/A
- INM N/A
- Industry
- MSI Radio And Television Broadcasting And Communications Equipment
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- MSI Technology
- INM Health Care
- Exchange
- MSI Nasdaq
- INM Nasdaq
- Market Cap
- MSI 72.8B
- INM 5.0M
- IPO Year
- MSI N/A
- INM N/A
- Fundamental
- Price
- MSI $444.43
- INM $2.06
- Analyst Decision
- MSI Buy
- INM
- Analyst Count
- MSI 9
- INM 0
- Target Price
- MSI $513.78
- INM N/A
- AVG Volume (30 Days)
- MSI 666.9K
- INM 116.0K
- Earning Date
- MSI 10-30-2025
- INM 11-13-2025
- Dividend Yield
- MSI 0.98%
- INM N/A
- EPS Growth
- MSI 45.12
- INM N/A
- EPS
- MSI 12.42
- INM N/A
- Revenue
- MSI $11,093,000,000.00
- INM $4,942,633.00
- Revenue This Year
- MSI $8.65
- INM N/A
- Revenue Next Year
- MSI $7.50
- INM N/A
- P/E Ratio
- MSI $35.81
- INM N/A
- Revenue Growth
- MSI 6.45
- INM 7.50
- 52 Week Low
- MSI $388.90
- INM $1.72
- 52 Week High
- MSI $507.82
- INM $8.27
- Technical
- Relative Strength Index (RSI)
- MSI 41.40
- INM 41.60
- Support Level
- MSI $434.47
- INM $2.04
- Resistance Level
- MSI $452.25
- INM $2.26
- Average True Range (ATR)
- MSI 7.23
- INM 0.14
- MACD
- MSI -0.85
- INM -0.01
- Stochastic Oscillator
- MSI 32.15
- INM 8.23
About MSI Motorola Solutions Inc.
Motorola Solutions is a leading provider of communications and analytics, primarily serving public safety departments as well as schools, hospitals, and businesses. The bulk of the firm's revenue comes from sales of land mobile radios and radio network infrastructure, but the firm also sells surveillance equipment and dispatch software. Most of Motorola's revenue comes from government agencies, while roughly 25% comes from schools and private businesses. Motorola has customers in over 100 countries and in every state in the United States.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.